Studies have shown that IGFBP7 is important for clinical staging of sepsis-related acute kidney injury (Molinari et al., 2022) because IGFBP7 can delay the progression of acute kidney injury by inhibiting RNF4/PARP1-mediated tubular injury (Yu et al., 2022). This evidence concerns the gene PARP1 and Sepsis.